Association of ANGPTL3 polymorphisms with high‐density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease. Issue 12 (24th October 2021)

• Record Type: Journal Article
• Authors: Aghasizadeh, Malihe; Nosrati, Mina; Saberi‐Karimian, Maryam; Safarian, Hamideh; Assadian, Parisa; Akbarpour, Ensieh; Sahebkar, Amirhosein; Avan, Amir; Ferns, Gordon A.; Kazemi, Tooba; Miri‐Moghaddam, Ebrahim; Ghayour‐Mobarhan, Majid
• Is Part Of: Journal of clinical laboratory analysis. Volume 35:Issue 12(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-24
• Subjects: angiopoietin‐like protein -- cardiovascular disease -- cholesterol uptake capacity -- polymorphism; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.23980
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract: Introduction: Previous studies have shown the importance of angiopoietin‐like 3 (ANGPTL3) as a modulator of lipid profiles. Cholesterol uptake capacity (CUC) is one means for assessing high‐density lipoprotein (HDL) functionality. This study for the first time has investigated the relationship between genetic ANGPTL3 polymorphism and CUC in patients with cardiovascular disease. Methods: Five hundred three subjects comprising 350 healthy subjects and 153 individuals who developed a cardiovascular disease (CVD) event during follow‐up were recruited as part of the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) cohort study. A modified CUC method was used to determine the CUC of serum samples. Applied amplification refractory mutation system PCR was performed for ANGPTL3 variants genotyping including: rs10789117, rs1748195, and rs11207997. Sanger sequencing was applied to confirm the genotypes. Results: The results showed that there was a significant relationship between the rs1748195 genotypes and HDL concentration in the CVD group ( p = 0.02). Moreover, individuals with a GG genotype of the rs1748195 were associated with a lower risk of CVD (OR = 0.49, 95% CI = 0.24–0.98, p = 0.04) compared with CC genotype in the CUC ≤ 1.7 a.u subgroup. Moreover, the CT genotype of rs11207997 was associated with a lower risk of CVD (OR = 0.74, 95% CI = 0.41–1.3, p = 0.01) compared with CC genotype in CUC > 1.7 a.u subgroup. Conclusion: The results showed that the CT genotype of the rs11207997 variant was associated with a lower risk of incident CVD in patients with higher HDL functionality. As well, the rs1748195 gene variant may contribute to a reduced risk of CVD. Abstract : Association of the genetic variant with concertation of HDL and cholesterol uptake capacity in studied population: rs1748195, CC, CG, GG, rs11207997, CC, CT, TT, rs10899117, AA, AC, CC; HDL (lower than <40 mg/dl in male and <50 mg/dl in female), Normal (than ≥40 mg/dl in male and ≥50 mg/dl in female); Cholesterol uptake capacity (CUC) (Lower than cutoff≤1.7), CUC (Higher than cutoff≥1.7); Re: Reference.